R21/Matrix-M is vaccine that showed promise against malaria. It was developed by scientists from the University of Oxford. It had the efficiency of 77 per cent over the period of 12 months during a trial in Burkina Faso. This is the first reach the WHO-specified 75% efficiency target. It will be launched for public use within the next two years. This vaccine will now undergo the final stage of trials in 4 African countries.


Leave a Reply